Admin touts TrumpRX success: it’s a quick fix, not real progress!  

Remember when President Trump said this during his State of the Union address last month? “I took prescription drugs, a very big part of health care, from the highest price in the entire world to the lowest. That’s a big achievement.”  

It’s a strong line. It’s also not true.  

A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries, especially places like Germany.  

And here’s why that matters: in Germany, patients often pay little to nothing out of pocket because the government negotiates prices and covers most of the cost. Even then, what their system pays is frequently lower than what the Trump administration negotiated here in the U.S.  

TrumpRx only covers a few dozen drugs out of thousands on the market. It leaves out many of the most commonly used medications and some of the most expensive medications, including many cancer treatments. Even among the drugs it........

© The Hill